An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) patients with a new all-tablet treatment showing impressive results.

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Mashable may earn an affiliate commission.

Rituximab, a monoclonal antibody directed against the CD20 molecule found on pre-B cells and mature B cells (but not on plasma cells), was introduced in the late 1990s for the treatment of non ...

leeds.ac.uk, edvital{at}gmail.com Objective To assess factors associated with primary and secondary non-response to rituximab in systemic lupus erythematosus (SLE) and evaluate management of secondary ...

mgh.harvard.edu We read with interest the article ‘Trimethoprim–sulfamethoxazole prophylaxis prevents severe/life-threatening infections following rituximab in antineutrophil cytoplasm ...

Regular tablets, like the iPad Mini, also make a great reading companion thanks to its bright display and access to multiple library apps. Ultimately, our testing considers all aspects of a ...

After selling out in barely 48 hours when it launched earlier this month, Lenovo has re-stocked the Legion Tab, its small yet powerful Android tablet. The Lenovo Legion Tab was announced at CES as ...